227 related articles for article (PubMed ID: 19070440)
1. Subjective, cognitive/psychomotor, and physiological effects of aripiprazole in Chinese light and heavy smokers.
Liu Y; Sun HQ; Bao YP; Li SX; Beveridge TJ; Di XL; Yang FD; Lu L
Drug Alcohol Depend; 2009 Apr; 101(1-2):42-52. PubMed ID: 19070440
[TBL] [Abstract][Full Text] [Related]
2. Long-term treatment with aripiprazole on the waking and postprandial urges to smoke in Chinese heavy smokers.
Liu Y; Bao YP; Sun HQ; Beveridge TJ; Li SX; Di XL; Yang FD; Lu L
J Clin Psychopharmacol; 2010 Aug; 30(4):373-80. PubMed ID: 20631555
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of a nicotine (4 mg)-containing lozenge on the cognitive impairment of nicotine withdrawal.
Atzori G; Lemmonds CA; Kotler ML; Durcan MJ; Boyle J
J Clin Psychopharmacol; 2008 Dec; 28(6):667-74. PubMed ID: 19011436
[TBL] [Abstract][Full Text] [Related]
4. Dose-related enhancement of mood and cognition in smokers administered nicotine nasal spray.
Myers CS; Taylor RC; Moolchan ET; Heishman SJ
Neuropsychopharmacology; 2008 Feb; 33(3):588-98. PubMed ID: 17443125
[TBL] [Abstract][Full Text] [Related]
5. Effects of the alpha4beta2 partial agonist varenicline on brain activity and working memory in abstinent smokers.
Loughead J; Ray R; Wileyto EP; Ruparel K; Sanborn P; Siegel S; Gur RC; Lerman C
Biol Psychiatry; 2010 Apr; 67(8):715-21. PubMed ID: 20207347
[TBL] [Abstract][Full Text] [Related]
6. High-dose transdermal nicotine and naltrexone: effects on nicotine withdrawal, urges, smoking, and effects of smoking.
Rohsenow DJ; Monti PM; Hutchison KE; Swift RM; MacKinnon SV; Sirota AD; Kaplan GB
Exp Clin Psychopharmacol; 2007 Feb; 15(1):81-92. PubMed ID: 17295587
[TBL] [Abstract][Full Text] [Related]
7. Smokers deprived of cigarettes for 72 h: effect of nicotine patches on craving and withdrawal.
Teneggi V; Tiffany ST; Squassante L; Milleri S; Ziviani L; Bye A
Psychopharmacology (Berl); 2002 Nov; 164(2):177-87. PubMed ID: 12404080
[TBL] [Abstract][Full Text] [Related]
8. Acute effects of glucose tablets on craving, withdrawal symptoms, and sustained attention in 12-h abstinent tobacco smokers.
Harakas P; Foulds J
Psychopharmacology (Berl); 2002 May; 161(3):271-7. PubMed ID: 12021830
[TBL] [Abstract][Full Text] [Related]
9. Effect of nicotine lozenges on affective smoking withdrawal symptoms: secondary analysis of a randomized, double-blind, placebo-controlled clinical trial.
Shiffman S
Clin Ther; 2008 Aug; 30(8):1461-75. PubMed ID: 18803988
[TBL] [Abstract][Full Text] [Related]
10. A randomized, multicenter, double-blind, placebo-controlled study of the efficacy and safety of aripiprazole for the treatment of alcohol dependence.
Anton RF; Kranzler H; Breder C; Marcus RN; Carson WH; Han J
J Clin Psychopharmacol; 2008 Feb; 28(1):5-12. PubMed ID: 18204334
[TBL] [Abstract][Full Text] [Related]
11. Acute doses of d-amphetamine and bupropion increase cigarette smoking.
Cousins MS; Stamat HM; de Wit H
Psychopharmacology (Berl); 2001 Sep; 157(3):243-53. PubMed ID: 11605079
[TBL] [Abstract][Full Text] [Related]
12. Ability of a new oral nicotine substitute to reduce smoking urge in moderate smokers.
Demazières A; Luthringer R; Coppel E; Gilles C; Fleury C; Roegel JC; Delarue A; Laur C; Lagrue G
Addict Behav; 2006 Mar; 31(3):537-43. PubMed ID: 15964703
[TBL] [Abstract][Full Text] [Related]
13. Effect of aripiprazole on cognition in the treatment of patients with schizophrenia.
Riedel M; Spellmann I; Schennach-Wolff R; Musil R; Dehning S; Cerovecki A; Opgen-Rhein M; Matz J; Seemüller F; Obermeier M; Severus E; Engel RR; Müller N; Möller HJ
Pharmacopsychiatry; 2010 Mar; 43(2):50-7. PubMed ID: 20336597
[TBL] [Abstract][Full Text] [Related]
14. Neurocognitive consequences of cigarette smoking in young adults--a comparison with pre-drug performance.
Fried PA; Watkinson B; Gray R
Neurotoxicol Teratol; 2006; 28(4):517-25. PubMed ID: 16904287
[TBL] [Abstract][Full Text] [Related]
15. A low dose of aripiprazole attenuates the subject-rated effects of d-amphetamine.
Stoops WW; Lile JA; Glaser PE; Rush CR
Drug Alcohol Depend; 2006 Sep; 84(2):206-9. PubMed ID: 16540264
[TBL] [Abstract][Full Text] [Related]
16. Subjective and physiological responses to smoking cues in smokers with schizophrenia.
Tidey JW; Rohsenow DJ; Kaplan GB; Swift RM
Nicotine Tob Res; 2005 Jun; 7(3):421-9. PubMed ID: 16085510
[TBL] [Abstract][Full Text] [Related]
17. The electronic-cigarette: effects on desire to smoke, withdrawal symptoms and cognition.
Dawkins L; Turner J; Hasna S; Soar K
Addict Behav; 2012 Aug; 37(8):970-3. PubMed ID: 22503574
[TBL] [Abstract][Full Text] [Related]
18. Aripiprazole for the treatment of psychoses in institutionalized patients with Alzheimer dementia: a multicenter, randomized, double-blind, placebo-controlled assessment of three fixed doses.
Mintzer JE; Tune LE; Breder CD; Swanink R; Marcus RN; McQuade RD; Forbes A
Am J Geriatr Psychiatry; 2007 Nov; 15(11):918-31. PubMed ID: 17974864
[TBL] [Abstract][Full Text] [Related]
19. Aripiprazole as a potential pharmacotherapy for stimulant dependence: human laboratory studies with d-amphetamine.
Stoops WW
Exp Clin Psychopharmacol; 2006 Nov; 14(4):413-21. PubMed ID: 17115868
[TBL] [Abstract][Full Text] [Related]
20. Aripiprazole, an antipsychotic with a novel mechanism of action, and risperidone vs placebo in patients with schizophrenia and schizoaffective disorder.
Potkin SG; Saha AR; Kujawa MJ; Carson WH; Ali M; Stock E; Stringfellow J; Ingenito G; Marder SR
Arch Gen Psychiatry; 2003 Jul; 60(7):681-90. PubMed ID: 12860772
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
